There needs to be a wide range of sexual health services for men who have sex with men.
In many parts of sub-Saharan Africa men who have sex with men encounter stigma and prejudice when accessing health services.
South Africa's data rollout of its pre-exposure prophylaxis shows that there is a relatively slow, but increasing, uptake. However, more needs to be done to target young women.
Three new HIV vaccine concepts which rely on high-tech designer proteins are being trialled to see if they can stop the virus.
There are several challenges that South Africa needs to address to bring HIV under control.
South Africa has made tremendous progress towards meeting the 90-90-90 targets but there are some challenges preventing it from reaching the goals set by UNAIDS.
Antiretroviral drugs suppress the HIV virus and stop progression of the disease.
The introduction of Pre Exposure Prophylaxis drugs in Kenya aims at reducing new HIV infections among people facing substantial ongoing risk.
A study of 78 Kenyan secondary schools shows up critical gaps in sex education.
At a time when a new national school curriculum is starting its pilot phase in Kenya, a study shows the massive gaps in sexuality education programmes.
Medical circumcision in settings where there are high rates of HIV will only be successful if these interventions take into account local beliefs about circumcision.
Philanthropist Bill Gates addresses delegates at the 2016 Aids Conference in Durban.
Bill Gates, who has been identified as the world's most significant donor in the fight against AIDS, shares his thoughts on the pandemic with Africa's most prominent HIV/AIDS academics.
There is a link between online social networking technologies and increased risky sexual behaviour.
Online social networking technologies have been linked with increased risky sexual behaviour -- and Swaziland is no different.
Pre-exposure prophylaxis is providing an exciting new innovation to tackle HIV prevention.
Trials have shown that rates of HIV infection are reduced if people not infected with HIV take anti-retrovirals - known as pre-exposure prophylaxis (PrEP). But adherence to a daily dose is a problem.
Doing it differently.
Ignoring those at 'high risk' of HIV in order to sustain the idea of the 'good' gay man will only perpetuate the virus.
For the next five years South Africa will be leading one of the latest large-scale trials for a vaccine for HIV.
Young women who attended the International AIDS Conference in Durban, South Africa.
International AIDS Society/Rogan Ward
The focus of the 2016 International AIDS Conference has on access to necessary antiretrovirals, equity and making sure no-one is left behind. But there is a funding gap that needs to be addressed.
PrEP works by preventing susceptible cells becoming infected with HIV. Truvada blocks the HIV virus from making copies of itself.
Efficacy is estimated to be as high as 99% in men who have sex with men who take Truvada daily.
If the vaginal ring becomes available for commercial use it will become one of the tools in the HIV prevention toolbox for women alongside female condoms and daily pre-exposure prophylaxis.
The successful prevention of mother to child transmission programmes means nearly all HIV-infected pregnant women should get anti-retroviral treatment to protect their babies.
Joshua Wanyama/Africa Knows
South Africa's programmes preventing HIV transmission from mothers to children have been hugely successful. But there are still gaps that need to be filled.
HIV services are not geared towards men even though they make up two-thirds of the HIV-related deaths globally.
Although men make up two-thirds of HIV-related deaths, there are not enough services geared towards helping them.
Advances in HIV treatment have turned it into a chronic, but manageable, illness. In this photo: Artist Damien Hirst’s ‘Where there’s a will there’s a way,’ which shows antiretroviral drugs in a medicine cabinet, is seen as it is displayed at a gallery in New York, February 4 2008.
Thanks to treatment advances, people with HIV can and do live long and full lives. And that has led to a challenge that doctors and patients may not have imagined 35 years ago: the aging HIV patient.
South Africa’s successes in HIV treatment have been marred by challenges in improving HIV prevention methods.
With nearly one-fifth of the globe's HIV positive population, South Africa has the largest anti-retroviral program in the world. But HIV prevention still presents a big challenge for the country.
Telling people to use a condom won’t prevent HIV because some women can’t convince their partner to use them.
Used properly and consistently, condoms are the most effective, affordable, and low-tech way to prevent HIV. But unfortunately, condoms are not an easy option for everyone – particularly women.